Home About us Articles Multimedia Search Instructions Login 
IF 2017: 1.596 (® Clarivate Analytics)
Total Cites: 7606
Q2 in Medicine, General & Internal
Follow Us
Follow Us
  • Users Online: 1902
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

Cheng Yong, Shi Xuan, Qu Jin-Feng, Zhao Ming-Wei, Li Xiao-Xin

Year : 2016| Volume: 129| Issue : 21 | Page no: 2610-2616

   This article has been cited by
1 Comparing Aflibercept Monotherapy With Aflibercept Plus Rescue Photodynamic Therapy in Polypoidal Choroidal Vasculopathy
David J. Browning
JAMA Ophthalmology. 2018; 136(7): 794
[Pubmed]  [Google Scholar] [DOI]
2 Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy
Un Chul Park,Joo Young Shin,Hum Chung,Hyeong Gon Yu
BMC Ophthalmology. 2017; 17(1)
[Pubmed]  [Google Scholar] [DOI]
3 Polypoidal Choroidal Vasculopathy
Joon-Bom Kim,Rajinder S. Nirwan,Ajay E. Kuriyan
Current Ophthalmology Reports. 2017; 5(2): 176
[Pubmed]  [Google Scholar] [DOI]
4 Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases
Zhihua Zhang,Xiaolu Yang,Huiyi Jin,Yuan Qu,Yuan Zhang,Kun Liu,Xun Xu
Scientific Reports. 2016; 6: 38326
[Pubmed]  [Google Scholar] [DOI]


Read this article